Cedric Francois - Feb 10, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Chief Executive Officer, Director
Signature: /s/David Watson, attorney-in-fact for Cedric Francois
Stock symbol: APLS
Transactions as of: Feb 10, 2022
Transactions value $: -$118,884
Form type: 4
Date filed: 2/14/2022, 05:20 PM
Previous filing: Feb 1, 2022
Next filing: Jan 17, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Tax liability	-$119K	-2.52K	-0.26%	$47.12	956K	Feb 10, 2022	Direct	F1
holding	APLS	Common Stock						300K	Feb 10, 2022	The Francois Grossi Trust	F2
holding	APLS	Common Stock						234K	Feb 10, 2022	The Francois-DuBois Educational Trust	F3

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents shares used to cover tax withholding on a Restricted Stock Unit release.
F2	The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F3	The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.